The UPLIFT (Understanding Potential Long-term Impacts on Function with Tiotropium) study is a randomized double-blind, parallel-group, 4-year trial. One of the largest COPD trials ever undertaken, UPLIFT was aimed at comparing treatment with tiotropium once daily to placebo in COPD patients. It involved 5,993 patients, aged 65±8 years, with a FEV1 of 1.32± 0.
E-Mail this Story
The UPLIFT (Understanding Potential Long-term Impacts on Function with Tiotropium) study is a randomized double-blind, parallel-group, 4-year trial. One of the largest COPD trials ever undertaken, UPLIFT was aimed at comparing treatment with tiotropium once daily to placebo in COPD patients. It involved 5,993 patients, aged 65±8 years, with a FEV1 of 1.32± 0.
